Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
FE$46.86+0.45(+0.98%)FirstEnergy Foundation Increases Support for Shelter, Safety and Stability The FirstEnergy Foundation has awarded $120,000 to 10 New Jersey nonprofit organizations that provide emergency shelter, housing assistance and...[2:15:00 PM ET]ORN$8.84+0.54(+6.51%)Orion Group Holdings Announces New Contract Awards of $250 Million[2:08:22 PM ET]MAPPF$0.10-0.00(-2.86%)ProStar CEO Michael Wolff Outlines Growth Strategy After First 90 Days[2:01:00 PM ET]SMX$1.82+0.04(+2.04%)MEDIA ALERT: TechCrunch Publishes Feature on SMX's Digital Material Identity Technology[2:00:00 PM ET]BJRI$63.48+2.97(+4.91%)BJ's Restaurant & Brewhouse Goes 'Bananas' with the New Nutella® Gone Bananas Pizookie® BJ's Restaurant & Brewhouse (NASDAQ: BJRI) is going bananas, and is bringing the whole table along! Introducing the Nutella® Gone Bananas Pizookie®,...[1:52:00 PM ET]DLTH$4.39+0.16(+3.78%)Best Workwear for Durability and Weather Protection? Duluth Trading Expands Fire Hose® Workwear with New Waxed Styles[1:50:00 PM ET]DCOM$42.19+0.33(+0.79%)Dime Commercial Bancshares Declares Quarterly Cash Dividend for Series A Preferred Stock[1:40:23 PM ET]TECK$63.60+0.56(+0.89%)Teck Announces Dividend[1:35:50 PM ET]UFPT$291.88+5.88(+2.06%)UFP Technologies to Report Third Quarter 2026 Financial Results on November 3, 2026[1:34:00 PM ET]

GRAL · NASDAQ

GRAIL, Inc.

$158.12 +0.30 (+0.19%)

Company overview

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age, and DAC, a diagnostic aid for cancer tests that accelerates diagnostic resolution for patients with a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Market cap
$7.1B
Employees
1,000
Headquarters
Menlo Park, CA
Website
grail.com
CEO
Robert Ragusa
Listed
June 12, 2024
P/E
-15.25
Dividend yield
0.00%

Company financials

Revenue
$156M
Gross profit
-$23.1M
Operating income
-$544M
EBITDA
-$360M
Net income
-$395M
EPS
-$10.37
Total assets
$2.8B
Total debt
$51M
Gross margin
-14.80%
Net margin
-253.22%
Earnings yield
-6.56%

Revenue segmentation

By product (FY 2025)

No product segmentation.

By region (FY 2025)

Showing FY 2025

Price chart

44.4676.13107.81139.49171.17
GRAL 1D NASDAQ O150.61H160.25L149.37C157.88+7.27 (+4.83%)Vol1.15M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
GRALGRAIL, Inc. Stock news GRAIL Q3 Earnings Ahead: Galleri Test Adoption to Drive Growth Zacks Investment Research
GRALGRAIL, Inc. Press release GRAIL to Present at the UBS Global Healthcare Conference GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company... PR Newswire
GRALGRAIL, Inc. Stock news 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps MarketBeat
GRALGRAIL, Inc. Press release GRAIL to Announce Third Quarter 2026 Financial Results GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, announced today that it will issue... PR Newswire
GRALGRAIL, Inc. Stock news GRAIL (NASDAQ:GRAL) Stock: Insider Joshua Ofman Sells 20,000 Shares Defense World
GRALGRAIL, Inc. Stock news GRAIL (NASDAQ:GRAL) Stock Price Down 5.6% on Insider Selling Defense World
GRALGRAIL, Inc. Stock news First-Class Amenity Kits Have Become Holy Grail Collectibles WSJ
GRALGRAIL, Inc. Stock news Grail Stock Hit a 12-Month High After Its FDA Panel Win. But Here's the Risk Investors Shouldn't Ignore. The Motley Fool
GRALGRAIL, Inc. Stock news Head to Head Contrast: Gilead Sciences (NASDAQ:GILD) vs. GRAIL (NASDAQ:GRAL) Defense World
GRALGRAIL, Inc. Stock news Why CVS Is ‘Insanely Cheap,' ON Semi a Laggard Catching Up, and Grail Too Expensive to Chase 24/7 Wall Street
GRALGRAIL, Inc. Press release GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at EDCC and ESMO Congress 2026 PRNewsWire
GRALGRAIL, Inc. Stock news Grail Stock Has Skyrocketed 171% in 6 Months. Where Will It Be in 5 Years? The Motley Fool
GRALGRAIL, Inc. Stock news GRAIL (NASDAQ:GRAL) Hits New 12-Month High – Should You Buy? Defense World
GRALGRAIL, Inc. Stock news 3 Reasons to Buy Grail (GRAL) Hand Over Fist in October The Motley Fool
GRALGRAIL, Inc. Stock news Grail Stock Has Soared 180% in 6 Months. Here's Why the Stock Has More Room to Run. The Motley Fool
GRALGRAIL, Inc. Stock news Insider Selling: GRAIL (NASDAQ:GRAL) CFO Sells $382,694.00 in Stock Defense World
GRALGRAIL, Inc. Stock news Here's Why Grail Stock Surged 55% This Week The Motley Fool
GRALGRAIL, Inc. Stock news Owning a Home Is Seen as a Financial Holy Grail. But What If It Isn't? WSJ
GRALGRAIL, Inc. Stock news Grail's Multi-Cancer Blood Test Gets FDA Committee Vote for Premarket Approval WSJ
GRALGRAIL, Inc. Stock news FDA advisers back safety of Grail's cancer test, narrowly endorses efficacy Reuters
See more
FAQ

Questions about GRAIL, Inc.

What does GRAIL, Inc. do?
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age, and DAC, a diagnostic aid for cancer tests that accelerates diagnostic resolution for patients with a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
What is GRAL's market cap?
GRAIL, Inc. (GRAL) is a listed stock with a live quote. The latest market cap on this page is $7.1B.
Where is GRAIL, Inc. headquartered?
GRAIL, Inc. is headquartered in Menlo Park, CA.
How do I get GRAL news from the API?
Call GET /v1/news?tickers=GRAL. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does GRAL news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for GRAL, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the GRAL price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs